Follow us on:
Breaking News
2026-04-06
Breaking News
Breaking News
page break 1
This Week at Contract Pharma
SamsungBio_Webinar_0426_ThisMonth@

Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics for $2.9B

 
Neurocrine Biosciences Agrees to Acquire Soleno Therapeutics for $2.9B

Expands its portfolio of innovative medicines and strengthens its leadership position in endocrinology and rare disease.
Read More >>

Headlines

Breaking News
Collaborations & Alliances

Akari Therapeutics Partners with WuXi XDC to Accelerate Development of Novel PH1 Payload

By targeting RNA splicing, PH1 may represent a new direction for next-generation ADC therapies.

SPONSOR

[WEBINAR] Operational Excellence for CDMOs: A Digital Workflow Strategy for Growth

Join ECOLAB and Contract Pharma for a webinar on May 6 to learn how leading CDMOs can drive growth using smarter workflows and digital tools to reduce bottlenecks and improve efficiency.  

Breaking News

Scinai Completes Corporate Reorganization Separating CDMO and R&D Operations

Aims to enhance capital efficiency, improve operational focus and position each business to independently create and capture value.

Breaking News

Thermo Fisher Introduces Gibco CTS Compleo Fill and Finish System 

Provides an automated, functionally closed approach to help streamline cell therapy manufacturing.

SPONSOR

[VIDEO] What Should Biotechs Look for in a CDMO?

Contract Pharma sits down with Rod Ketner, VP of Business Operations at Serán Bioscience, for his thoughts.

Interphex_Enl_041326_650x250

Breaking News

GC Biopharma Validates Proprietary Technology to Mitigate Thromboembolic Risks

The company’s proprietary assay effectively mitigates heterophilic antibody interference to precisely measure a critical impurity.

SPONSOR

[eBook] Mastering Supply Chain Traceability

A must-read guide for pharmaceutical professionals navigating the complexities of DSCSA compliance and supply chain digitalization.

Featured Resources

Solution Content Centers SPOTLIGHT

Solvias

Solvias is a global provider of CMC analytics to the pharmaceutical and biotech industry. Our expert teams combine 25 years of experience with regulatory understanding across small molecules, biologics, and cell and gene therapies. We offer comprehensive solutions from raw materials to drug substance & product to final release testing.

 

Solution Center SPOTLIGHT

Quality Chemical Laboratories (QCL)

QCL is a CDMO privately owned and operated since 1998. We excel in pre-formulation, formulation development, and delivering early phase clinical trial materials on aggressive timelines. We provide analytical development and validation, stability studies, and testing of small and large molecule APIs, finished products, and raw materials. New construction doubles our footprint to 200,000 sq. ft., expanding services into late phase clinical and small scale commercial GMP manufacturing including state of the art sterile fill-finish for both small and large molecules.